What are the professional and logistic demands to appropriately follow patients with an implantable cardioverter-defibrillator?

Journal of Internal Medicine

Volumn 260, Issue 1, 2006, Pages 88-92

  Schaer, B A ^a   Sticherling, C ^a   Osswald, S ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Implantable cardioverter defibrillator; Inappropriate ICD therapy; Outpatient clinic

Indexed keywords

ARTICLE; AUTOMATED EXTERNAL DEFIBRILLATOR; CONSULTATION; COURSE EVALUATION; DEVICE; DIZZINESS; EVALUATION; FOLLOW UP; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; SAMPLE SIZE; SKILL; SYNCOPE; UNIVERSITY HOSPITAL;

AFTER-HOURS CARE; CARDIOLOGY SERVICE, HOSPITAL; CLINICAL COMPETENCE; DEFIBRILLATORS, IMPLANTABLE; EMERGENCIES; HEALTH SERVICES RESEARCH; HUMANS; LONG-TERM CARE; OUTPATIENT CLINICS, HOSPITAL; PROSPECTIVE STUDIES; SWITZERLAND;

EID: 33745168234     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2006.01656.x     Document Type: Article

References (21)

1. Moss AJ Hall WJ Cannom DS et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996 335: 1933 40.
2. Buxton AE Lee KL Fisher JD Josephson ME Prystowsky EN Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999 341: 1882 90.
3. Moss AJ Zareba W Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 346: 877 83.
4. Kadish A Dyer A Daubert JP et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004 350: 2151 8.
5. Bardy GH Lee KL Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352: 225 37.
6. Hohnloser SH Kuck KH Dorian P et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004 351: 2481 8.
7. Sticherling C Schaumann A Klingenheben T Hohnloser SH for the Ventak AV II DR Investigators. First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator. Europace 1999 1: 96 102.
8. Sticherling C Klingenheben T Cameron D Hohnloser SH for the Worldwide 7221 ICD Investigators, Worldwide clinical experience with a down-sized active can implantable cardioverter-defibrillator in 162 consecutive patients. Worldwide 7221 ICD Investigators. Pacing Clin Electrophysiol 1998 21: 1778 83.
9. Sinha AM Stellbrink C Schuchert A et al. Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator. J Cardiovasc Electrophysiol 2004 15: 646 52.
10. Wiegand UK LeJeune D Boguschewski F et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/ anticoagulation therapy. Chest 2004 126: 1177 86.
11. Credner SC Klingenheben T Mauss O Sticherling C Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol 1998 32: 1909 15.
12. Takahashi T Bhandari AK Watanuki M Cannom DS Sakurada H Hiraoka M. High incidence of device-related and lead-related complications in the dual-chamber implantable cardioverter defibrillator compared with the single-chamber version. Circ J 2002 66: 746 50.
13. Chua JD Wilkoff BL Lee I Juratli N Longworth DL Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000 133: 604 8.
14. Hauser RG Kallinen L. Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States Food and Drug Administration Manufacturer and User Facility Device Experience Database. Heart Rhythm 2004 1: 399 405.
15. Ladwig KH Wirsching CV Hammerstein A Danner R Baumert J Schmitt C. Anxiety and anxiety management in patients with implanted cardioverter- defibrillators. Dtsch Med Wochenschr 2004 129: 2311 5.
16. Shea JB. Quality of life issues in patients with implantable cardioverter defibrillators: driving, occupation, and recreation. AACN Clin Issues 2004 15: 478 89.
17. Herrmann-Lingen C Fritzsche K Kanwischer H Drinkmann A Rabung S Bergmann G. Cardiological and psychosocial status of patients with malignant ventricular arrhythmias before implantation of a cardioverter defibrillator. First results from the German Austrian ICD Multicenter Study (GAIMS). Psychother Psychosom Med Psychol 2004 54: 308 19.
18. Klein T Schonecke O Wollny H Konig J Fries R. Clinical significance of stress reactivity for frequency of electric shock discharges in patients with implanted cardioverter-defibrillators. Dtsch Med Wochenschr 2004 129: 2291 4.
19. Hayes DL Naccarelli GV Furman S et al. NASPE training requirements for cardiac implantable electronic devices: selection, implantation, and follow-up. Pacing Clin Electrophysiol 2003 267: 1556 62.
20. Breithardt G Hohnloser SH Andresen D et al. for the German cardiac society. Guidelines for implantation of automatic cardioverter/defibrillator. Z Kardiol 2000 89: 136 43.
21. Joseph GK Wilkoff BL Dresing T Burkhardt J Khaykin Y. Remote interrogation and monitoring of implantable cardioverter defibrillators. J Interv Card Electrophysiol 2004 11: 161 6.